Update of the NQO gene family UPDATE ON GENE COMPLETIONS ARNeDviAeNwNOTATIONS References 1. Ernster, L. (1967), ‘DT-diaphorase’, Methods Enzymol. Vol. 10, pp. 309 – 317. 2. Lind, C., Cadenas, E., Hochstein, P. et al. (1990), ‘DT-diaphorase. Puriﬁcation, properties and function’, Methods Enzymol. Vol. 186, pp. 287 – 301. 3. Siegel, D., Gibson, N.W., Preusch, P.C. et al. (1990), ‘Metabolism of mitomycin C by DT-diaphorase: Role in mitomycin C-induced DNA damage and cytotoxicity in human colon carcinoma cells’, Cancer Res. Vol. 50, pp. 7483 – 7489. 4. Gibson, N.W., Hartley, J.A., Butler, J. et al. (1992), ‘Relationship between DT-diaphorase-mediated metabolism of a series of aziridinylbenzoqui- nones and DNA damage and cytotoxicity’, Mol. Pharmacol. Vol. 42, pp. 531 – 536. 5. Ross, D., Siegel, D., Beall, H. et al. (1993), ‘DT-diaphorase in activation and detoxiﬁcation of quinones. Bioreductive activation of mitomycin C’, Cancer Metastasis Rev. Vol. 12, pp. 83 – 101. 6. Ross, D., Beall, H., Traver, R.D. et al. (1994), ‘Bioactivation of quinones by DT-diaphorase. Molecular, biochemical, and chemical studies’, Oncol. Res. Vol. 6, pp. 493 – 500. 7. Ernster, L. and Navazio, F. (1958), ‘Soluble diaphorase in animal tissues’, Acta Chem. Scand. Vol. 12, pp. 595 – 602. 8. Ernster, L. (1958), ‘Diaphorase activities in liver cytoplasmic fractions’, Fed. Proc. Vol. 17, p. 216. 9. Ernster, L. (1987), ‘DT-diaphorase: A historical review’, Chem. Scripta Vol. 27A, pp. 1 – 13. 10. Martius, C. (1954), ‘Die Stellung des Phyllochinons (Vitamin K1) in der Atmungskette’, Biochem. Z. Vol. 326, pp. 26 – 27. 11. Nebert, D.W., Roe, A.L., Dieter, M.Z. et al. (2000), ‘Role of the aromatic hydrocarbon receptor and [Ah] gene battery in the oxidative stress response, cell cycle control, and apoptosis’, Biochem. Pharmacol. Vol. 59, pp. 65 – 85. 12. Li, R., Bianchet, M.A., Talalay, P. et al. (1995), ‘The three-dimensional structure of NAD(P)H:quinone reductase, a ﬂavoprotein involved in cancer chemoprotection and chemotherapy. Mechanism of the two-electron reduction’, Proc. Natl. Acad. Sci. USA Vol. 92, pp. 8846 – 8850. 13. Ross, D. (2004), ‘Quinone reductases. Multitasking in the metabolic world’, Drug Metab. Rev. Vol. 36, pp. 639 – 654. 14. Ross, D. and Siegel, D. (2004), ‘NAD(P)H:quinone oxidoreductase-1 (NQO1, DT-diaphorase), functions, and pharmacogenetics’, Methods Enzymol. Vol. 382, pp. 115 – 144. 15. Rothman, N., Smith, M.T., Hayes, R.B. et al. (1996), ‘An epidemiologic study of early biologic effects of benzene in Chinese workers’, Environ. Health Perspect. Vol. 104(Suppl. 6), pp. 1365 – 1370. 16. Pan, S.S., Forrest, G.L., Akman, S.A. et al. (1995), ‘NAD(P)H:quinone oxidoreductase expression and mitomycin C resistance developed by human colon cancer HCT 116 cells’, Cancer Res. Vol. 55, pp. 330 – 335. 17. Gaedigk, A., Tyndale, R.F., Jurima-Romet, M. et al. (1998), ‘NAD(P)H:quinone oxidoreductase: Polymorphisms and allelic frequencies in caucasian. Chinese and Canadian native Indian and inuit populations’, Pharmacogenetics Vol. 8, pp. 305 – 313. 18. Jaiswal, A.K., Burnett, P., Adesnik, M. et al. (1990), ‘Nucleotide and deduced amino acid sequence of a human cDNA (NQO2) corresponding to a second member of the NAD(P)H:quinone oxidoreductase gene family. Extensive polymorphism at the NQO2 gene locus on chromosome 6’, Biochemistry Vol. 29, pp. 1899 – 1906. 19. Zhao, Q., Yang, X.L., Holtzclaw, W.D. et al. (1997), ‘Unexpected genetic and structural relationships of a long-forgotten ﬂavoenzyme to NAD(P)H:quinone reductase (DT-diaphorase)’, Proc. Natl. Acad. Sci. USA Vol. 94, pp. 1669 – 1674. 20. Harada, S., Fujii, C., Hayashi, A. et al. (2001), ‘An association between idiopathic Parkinson disease and polymorphisms of phase II detoxiﬁcation enzymes: Glutathione S-transferase M1 and quinone oxidoreductase 1 and 2’, Biochem. Biophys. Res. Commun. Vol. 288, pp. 887 – 892. 21. Shao, M., Liu, Z., Tao, E. et al. (2001), ‘Polymorphism of MAOB gene and NAD(P)H:quinone oxidoreductase gene in Parkinson disease’, Zhonghua Yi. Xue. Yi. Chuan Xue. Za Zhi. Vol. 18, pp. 122 – 124. 22. Okada, S., Farin, F.M., Stapleton, P. et al. (2005), ‘No associations between Parkinson’s disease and polymorphisms of the quinone oxidoreductase (NQO1, NQO2) genes’, Neurosci. Lett. Vol. 375, pp. 178 – 180. 23. Foster, C.E., Bianchet, M.A., Talalay, P. et al. (1999), ‘Crystal structure of human quinone reductase type-2, a metalloﬂavoprotein’, Biochemistry Vol. 38, pp. 9881 – 9886. 24. Vella, F., Ferry, G., Delagrange, P. et al. (2005), ‘NRH:quinone reductase- 2: An enzyme of surprises and mysteries’, Biochem. Pharmacol. Vol. 71, pp. 1 – 12. 25. Mulder, N.J., Apweiler, R., Attwood, T.K. et al. (2005), ‘InterPro, progress and status in 2005’, Nucleic Acids Res. Vol. 33, pp. D201 – D205. 26. Torrents, E., Roca, I. and Gibert, I. (2003), ‘Corynebacterium ammo- niagenes class Ib ribonucleotide reductase: Transcriptional regulation of an atypical genomic organization in the nrd cluster’, Microbiology Vol. 149, pp. 1011 – 1020. 27. Danson, S., Ward, T.H., Butler, J. et al. (2004), ‘DT-diaphorase: A target for new anticancer drugs’, Cancer Treat. Rev. Vol. 30, pp. 437 – 449. 28. Corran, H.S., Green, D.E. and Straub, F.B. (1939), ‘On the catalytic function of heart ﬂavoprotein’, Biochem. J. Vol. 33, pp. 793 – 801. 29. Edwards, Y.H., Potter, J. and Hopkinson, D.A. (1980), ‘Human FAD-dependent NAD(P)H diaphorase’, Biochem. J. Vol. 187, pp. 429 – 436. 30. Kaplan, J.C. and Leroux, A. (1970), ‘Les systemes NADH et NADPH diaphorasiques des cellules sanguines humaines’, Bull. Soc. Chim. Biol. Vol. 52, pp. 1243 – 1249. 31. Leroux, A., Junien, C. and Kaplan, J.C. (1975), ‘Generalised deﬁciency of cytochrome b5 reductase in congenital methaemoglobinaemia with mental retardation’, Nature Vol. 258, pp. 619 – 620. 32. Shaw, P.M., Reiss, A., Adesnik, M. et al. (1991), ‘The human dioxin- inducible NAD(P)H:quinone oxidoreductase cDNA encoded protein expressed in COS-1 cells is identical to diaphorase-4’, Eur. J. Biochem. Vol. 195, pp. 171 – 176. 33. Greenshields, D., Liu, G., Selvaraj, G. et al. (2005), ‘Differential regulation of wheat quinone reductases in response to powdery mildew infection’, Planta Vol. 222, pp. 867 – 875. 34. Matvienko, M., Wojtowicz, A., Wrobel, R. et al. (2001), ‘Quinone oxidoreductase message levels are differentially regulated in parasitic and non-parasitic plants exposed to allelopathic quinones’, Plant J. Vol. 25, pp. 375 – 387. 35. Rasmusson, A.G., Soole, K.L. and Elthon, T.E. (2004), ‘Alternative NAD(P)H dehydrogenases of plant mitochondria’, Annu. Rev. Plant Biol. Vol. 55, pp. 23 – 39. 36. Brustugun, O.T., Fladmark, K.E., Doskeland, S.O. et al. (1998), ‘Apoptosis induced by microinjection of cytochrome c is caspase-dependent and is inhibited by BCL2’, Cell Death. Differ. Vol. 5, pp. 660 – 668. 37. Kirsch, D.G., Doseff, A., Chau, B.N. et al. (1999), ‘Caspase-3-dependent cleavage of BCL2 promotes release of cytochrome c’, J. Biol. Chem. Vol. 274, pp. 21155 – 21161. 38. Martinou, J.C. (1999), ‘Apoptosis. Key to the mitochondrial gate’, Nature Vol. 399, pp. 411 – 412. 39. Shimizu, S., Narita, M. and Tsujimoto, Y. (1999), ‘BCL2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC’, Nature Vol. 399, pp. 483 – 487. 40. Lesser, M.P. (2006), ‘Oxidative stress in marine environments: biochemistry and physiological ecology’, Annu. Rev. Physiol. Vol. 68, pp. 253 – 278. 41. Buttke, T.M. and Sandstrom, P.A. (1994), ‘Oxidative stress as a mediator of apoptosis’, Immunol. Today Vol. 15, pp. 7 – 10. q HENRY STEWART PUBLIC ATIONS 1473-9542. HUMAN GENOMICS. VOL 2. NO 5. 329–335 MARCH 2006 335